301188 力诺药包
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.7662.5364.2434.4078.356
总资产报酬率 ROA (%)1.1251.5672.9323.4787.289
投入资产回报率 ROIC (%)1.2941.8023.2703.8138.107

边际利润分析
销售毛利率 (%)22.65621.12519.01017.43822.093
营业利润率 (%)5.9805.1586.6727.69415.445
息税前利润/营业总收入 (%)7.6777.5108.2088.19214.398
净利润/营业总收入 (%)4.6304.0416.1136.95814.191

收益指标分析
经营活动净收益/利润总额(%)88.44155.58084.37677.05585.159
价值变动净收益/利润总额(%)9.84025.45318.51819.25611.223
营业外收支净额/利润总额(%)2.248-2.849-0.932-0.109-0.189

偿债能力分析
流动比率 (X)2.3643.0774.0887.0734.773
速动比率 (X)1.4742.0693.2796.0053.930
资产负债率 (%)31.00141.84834.03227.46112.729
带息债务/全部投入资本 (%)17.45028.94321.00219.9522.022
股东权益/带息债务 (%)453.370231.775359.905394.1364,801.712
股东权益/负债合计 (%)222.569138.962193.840264.157685.633
利息保障倍数 (X)4.9223.0105.13716.164-14.146

营运能力分析
应收账款周转天数 (天)70.47481.23565.40862.86864.708
存货周转天数 (天)168.001169.78998.15985.14179.734